Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
0.1598
Dollar change
-0.0004
Percentage change
-0.25
%
Index- P/E- EPS (ttm)-0.61 Insider Own8.38% Shs Outstand64.39M Perf Week-4.31%
Market Cap10.30M Forward P/E- EPS next Y-0.09 Insider Trans-26.51% Shs Float59.08M Perf Month-2.92%
Income-39.11M PEG- EPS next Q-0.11 Inst Own35.46% Short Float3.08% Perf Quarter-42.74%
Sales0.01M P/S1030.39 EPS this Y12.93% Inst Trans-65.54% Short Ratio1.62 Perf Half Y-94.19%
Book/sh0.31 P/B0.51 EPS next Y82.18% ROA-90.71% Short Interest1.82M Perf Year-88.50%
Cash/sh0.35 P/C0.46 EPS next 5Y- ROE-104.49% 52W Range0.15 - 3.53 Perf YTD-93.23%
Dividend Est.- P/FCF- EPS past 5Y13.11% ROI-194.96% 52W High-95.47% Beta2.04
Dividend TTM- Quick Ratio5.48 Sales past 5Y-53.76% Gross Margin-3102.77% 52W Low9.23% ATR (14)0.01
Dividend Ex-Date- Current Ratio5.48 EPS Y/Y TTM7.48% Oper. Margin-408772.17% RSI (14)42.40 Volatility6.10% 6.12%
Employees35 Debt/Eq0.02 Sales Y/Y TTM-86.67% Profit Margin-391135.91% Recom3.00 Target Price0.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-21.87% Payout- Rel Volume0.20 Prev Close0.16
Sales Surprise- EPS Surprise7.46% Sales Q/Q- EarningsAug 01 Avg Volume1.13M Price0.16
SMA20-2.46% SMA50-10.55% SMA200-88.68% Trades Volume220,443 Change-0.25%
Date Action Analyst Rating Change Price Target Change
Jul-26-24Downgrade TD Cowen Buy → Hold
Dec-22-23Initiated CapitalOne Overweight $12
Nov-12-21Upgrade Jefferies Hold → Buy $3 → $4
Nov-14-19Initiated ROTH Capital Buy $12
Aug-05-19Downgrade SunTrust Buy → Hold $23 → $5
Aug-05-19Downgrade Piper Jaffray Overweight → Neutral $20 → $6
Aug-05-19Downgrade Jefferies Buy → Hold
Apr-12-19Initiated Piper Jaffray Overweight $20
Dec-18-18Initiated H.C. Wainwright Buy $24
Jul-26-16Initiated SunTrust Buy
Jul-25-24 09:00AM
Jul-22-24 07:00AM
Jun-26-24 07:41AM
Jun-25-24 07:37AM
Jun-04-24 07:00AM
04:01PM Loading…
May-29-24 04:01PM
May-28-24 04:05AM
May-09-24 10:58PM
07:19PM
May-08-24 07:42AM
May-07-24 05:21AM
May-06-24 03:53PM
12:45PM
08:40AM
07:52AM
07:28AM Loading…
07:28AM
06:00AM
Apr-25-24 07:00AM
Mar-28-24 10:12AM
02:10AM
Mar-27-24 11:53AM
10:31AM
07:14AM
07:00AM
Mar-21-24 08:50AM
Mar-13-24 07:00AM
Feb-26-24 07:00AM
Feb-12-24 07:00AM
Jan-04-24 07:00AM
Jan-03-24 07:00AM
12:00PM Loading…
Dec-10-23 12:00PM
Nov-09-23 07:00AM
Nov-05-23 08:51AM
Nov-04-23 01:48AM
Nov-03-23 10:33AM
07:07AM
07:00AM
Oct-23-23 08:30AM
Oct-20-23 07:00AM
Sep-06-23 07:00AM
Sep-05-23 07:00AM
Aug-17-23 07:00AM
Aug-02-23 07:17AM
07:00AM
Jul-19-23 07:00AM
Jul-13-23 09:29AM
Jun-26-23 08:00AM
Jun-15-23 08:00AM
Jun-12-23 11:13AM
May-31-23 07:00AM
May-16-23 10:37AM
May-03-23 10:17PM
07:23AM
07:00AM
Apr-26-23 07:00AM
Apr-19-23 10:20AM
Apr-05-23 01:45PM
Mar-31-23 04:30AM
Mar-29-23 07:00AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 07:00AM
06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 07:00AM
06:01AM
06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
Feb-24-23 07:17AM
07:17AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-14-23 06:23AM
Feb-06-23 07:00AM
Jan-22-23 07:30AM
07:24AM
Dec-30-22 07:17AM
Dec-28-22 06:58AM
Dec-26-22 07:14AM
Dec-19-22 09:40AM
Dec-12-22 07:00AM
Dec-02-22 01:18PM
09:40AM
Nov-23-22 09:55AM
Nov-16-22 09:40AM
Nov-12-22 07:14AM
Nov-10-22 09:12AM
Nov-09-22 07:00AM
Nov-08-22 04:05PM
Nov-03-22 09:00AM
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Invus Public Equities, L.P.10% OwnerAug 08 '24Sale0.19260,87350,0096,317,565Aug 09 04:30 PM
Invus Public Equities, L.P.10% OwnerAug 07 '24Sale0.1861,48811,1976,578,438Aug 09 04:30 PM
Invus Public Equities, L.P.10% OwnerAug 05 '24Sale0.19164,52330,9966,695,658Aug 07 04:30 PM
Invus Public Equities, L.P.10% OwnerAug 06 '24Sale0.1855,73210,1886,639,926Aug 07 04:30 PM
Invus Public Equities, L.P.10% OwnerAug 02 '24Sale0.20286,20057,3546,860,181Aug 05 04:53 PM
Invus Public Equities, L.P.10% OwnerAug 01 '24Sale0.2263,56413,7437,146,381Aug 05 04:53 PM
Invus Public Equities, L.P.10% OwnerJul 30 '24Sale0.22756,835167,1857,209,945Jul 30 05:16 PM
Invus Public Equities, L.P.10% OwnerJul 29 '24Sale0.24363,94985,6377,966,780Jul 30 05:16 PM
Invus Public Equities, L.P.10% OwnerJul 26 '24Sale0.24258,33562,4408,330,729Jul 30 05:16 PM
Rock EdwinChief Medical OfficerJun 20 '24Buy0.25190,00048,108565,403Jun 24 04:29 PM
Rock EdwinChief Medical OfficerJun 21 '24Buy0.27115,00030,716680,403Jun 24 04:29 PM
Hahn Brian M.SVP Finance, CFOJun 18 '24Buy0.2517,5004,33570,643Jun 20 04:15 PM